Advertisement

Risk factors and outcomes of acute lower gastrointestinal bleeding in intestinal Behçet’s disease

  • Jihye Park
  • Jae Hee CheonEmail author
  • Yong Eun Park
  • Yoon Jee Lee
  • Hyun Jung Lee
  • Soo Jung Park
  • Sung Pil Hong
  • Tae Il Kim
  • Won Ho Kim
Short Communication

Abstract

Background

Intestinal Behçet’s disease (BD) can cause acute lower gastrointestinal bleeding, which is sometimes fatal.

Aim

We aimed to identify the risk factors and outcomes of acute lower gastrointestinal bleeding and factors associated with rebleeding in intestinal BD patients.

Methods

Of the total of 588 intestinal BD patients, we retrospectively reviewed the medical records of 66 (11.2%) patients with acute lower gastrointestinal bleeding and compared them with those of 132 matched patients without bleeding.

Results

The baseline characteristics were comparable between the bleeding group (n = 66) and the non-bleeding group (n = 132). On multivariate analysis, the independent factors significantly associated with lower gastrointestinal bleeding were older age (>52 years) (hazard ratio [HR] 2.2, 95% confidence interval [CI] 1.058–4.684, p = 0.035) and a nodular ulcer margin (HR 7.1, 95% CI 2.084–24.189, p = 0.002). Rebleeding occurred in 23 patients (34.8%). Female patients (p = 0.044) and those with previous use of corticosteroids or azathioprine (p = 0.034) were more likely to develop rebleeding. On multivariate analysis, only use of steroids or azathioprine was significantly associated with rebleeding (HR 3.2, 95% CI 1.070–9.462, p = 0.037).

Conclusions

Age >52 years and the presence of a nodular margin of the ulcer were found to be related to increased risk of bleeding in patients with intestinal BD. Rebleeding is not uncommon and not effectively prevented with currently available medications. Further studies are warranted to identify effective measures to decrease rebleeding in intestinal BD.

Keywords

Behçet’s disease Gastrointestinal hemorrhage Risk factor Outcome Rebleeding 

Notes

Author contributions

Jihye Park: acquisition of data; analysis and interpretation of data; drafting of the manuscript. Yong Eun Park: acquisition of data. Yoon Jee Lee: acquisition of data. Hyun Jung Lee: study concept and design; critical revision of the manuscript for important intellectual content. Soo Jung Park: study concept and design; critical revision of the manuscript for important intellectual content. Sung Pil Hong: study concept and design; critical revision of the manuscript for important intellectual content. Tae Il Kim: study concept and design; critical revision of the manuscript for important intellectual content. Won Ho Kim: study concept and design; critical revision of the manuscript for important intellectual content. Jae Hee Cheon: acquisition of data; study concept and design; critical revision of the manuscript for important intellectual content.

Compliance with ethical standards

This study was conducted in accordance with the ethical guidelines of the Declaration of Helsinki and approved by the ethics committee of Severance Hospital.

Conflict of interest

The authors declare that they have no conflict of interest.

Guarantor of the article

Jae Hee Cheon.

Funding sources

This research was supported by two grants (A120176, HI13C1345) from the Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), which is funded by the Ministry of Health and Welfare, Republic of Korea. This work was also supported by two grants (NRF-2013R1A2A2A01067123, NRF-2014R1A1A1008096) from the Basic Science Research Program through the National Research Foundation of Korea, which is funded by the Ministry of Science, ICT and Future Planning. In addition, this work was supported by a faculty research grant (2012-31-0477) from the Department of Internal Medicine, Yonsei University, College of Medicine.

References

  1. 1.
    James DG (1979) Behcet’s syndrome. N Engl J Med 301(8):431–432. doi: 10.1056/NEJM197908233010811 CrossRefPubMedGoogle Scholar
  2. 2.
    Sakane T, Takeno M, Suzuki N, Inaba G (1999) Behcet’s disease. N Engl J Med 341(17):1284–1291. doi: 10.1056/NEJM199910213411707 CrossRefPubMedGoogle Scholar
  3. 3.
    Bayraktar Y, Ozaslan E, Van Thiel DH (2000) Gastrointestinal manifestations of Behcet’s disease. J Clin Gastroenterol 30(2):144–154CrossRefPubMedGoogle Scholar
  4. 4.
    Dilsen N, Konice M, Aral O, Ocal L, Inanc M, Gul A (1993) Comparative study of the skin pathergy test with blunt and sharp needles in Behcet’s disease: confirmed specificity but decreased sensitivity with sharp needles. Ann Rheum Dis 52(11):823–825CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Cheon JH, Kim WH (2015) An update on the diagnosis, treatment, and prognosis of intestinal Behcet’s disease. Curr Opin Rheumatol 27(1):24–31. doi: 10.1097/BOR.0000000000000125 CrossRefPubMedGoogle Scholar
  6. 6.
    Cheon JH, Shin SJ, Kim SW, Lee KM, Kim JS, Kim WH, Diseases IBDSGotKAotSoI (2009) Diagnosis of intestinal Behcet’s disease. Korean J Gastroenterol 53(3):187–193PubMedGoogle Scholar
  7. 7.
    Ebert EC (2009) Gastrointestinal manifestations of Behcet’s disease. Dig Dis Sci 54(2):201–207. doi: 10.1007/s10620-008-0337-4 CrossRefPubMedGoogle Scholar
  8. 8.
    Kim DH, Cheon JH (2016) Intestinal Behcet’s disease: a true inflammatory bowel disease or merely an intestinal complication of systemic vasculitis? Yonsei Med J 57(1):22–32. doi: 10.3349/ymj.2016.57.1.22 CrossRefPubMedGoogle Scholar
  9. 9.
    Hisamatsu T, Naganuma M, Matsuoka K, Kanai T (2014) Diagnosis and management of intestinal Behcet’s disease. Clin J Gastroenterol 7(3):205–212. doi: 10.1007/s12328-014-0488-0 CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Jung YS, Yoon JY, Lee JH, Jeon SM, Hong SP, Kim TI, Kim WH, Cheon JH (2011) Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet’s disease. Inflamm Bowel Dis 17(7):1594–1602. doi: 10.1002/ibd.21517 CrossRefPubMedGoogle Scholar
  11. 11.
    Eker T, Eroglu A (2015) Multiple small bowel perforations due to Behcet’s disease. Ulus Travma Acil Cerrahi Derg 21(4):300–302. doi: 10.5505/tjtes.2015.87925 PubMedGoogle Scholar
  12. 12.
    Li G, Ren J, Wang G, Wu Q, Gu G, Ren H, Liu S, Hong Z, Li R, Li Y, Guo K, Wu X, Li J (2015) Prevalence and risk factors of acute lower gastrointestinal bleeding in Crohn disease. Medicine (Baltimore) 94(19):e804. doi: 10.1097/MD.0000000000000804 CrossRefGoogle Scholar
  13. 13.
    Kim KJ, Han BJ, Yang SK, Na SY, Park SK, Boo SJ, Park SH, Yang DH, Park JH, Jeong KW, Ye BD, Byeon JS, Myung SJ, Kim JH (2012) Risk factors and outcome of acute severe lower gastrointestinal bleeding in Crohn’s disease. Dig Liver Dis 44(9):723–728. doi: 10.1016/j.dld.2012.03.010 CrossRefPubMedGoogle Scholar
  14. 14.
    Skef W, Hamilton MJ, Arayssi T (2015) Gastrointestinal Behcet’s disease: a review. World J Gastroenterol 21(13):3801–3812. doi: 10.3748/wjg.v21.i13.3801 CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Zuckerman GR, Prakash C (1998) Acute lower intestinal bleeding: part I: clinical presentation and diagnosis. Gastrointest Endosc 48(6):606–617CrossRefPubMedGoogle Scholar
  16. 16.
    Committee ASoP, Pasha SF, Shergill A, Acosta RD, Chandrasekhara V, Chathadi KV, Early D, Evans JA, Fisher D, Fonkalsrud L, Hwang JH, Khashab MA, Lightdale JR, Muthusamy VR, Saltzman JR, Cash BD (2014) The role of endoscopy in the patient with lower GI bleeding. Gastrointest Endosc 79(6):875–885. doi: 10.1016/j.gie.2013.10.039 CrossRefGoogle Scholar
  17. 17.
    Park SJ, Kim WH, Cheon JH (2014) Clinical characteristics and treatment of inflammatory bowel disease: a comparison of Eastern and Western perspectives. World J Gastroenterol 20(33):11525–11537. doi: 10.3748/wjg.v20.i33.11525 CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Kim B, Park SJ, Hong SP, Cheon JH, Kim TI, Kim WH (2015) Overlooked management and risk factors for anemia in patients with intestinal Behcet’s disease in actual clinical practice. Gut Liver 9(6):750–755. doi: 10.5009/gnl14193 CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Jung YS, Cheon JH, Park SJ, Hong SP, Kim TI, Kim WH (2013) Clinical course of intestinal Behcet’s disease during the first five years. Dig Dis Sci 58(2):496–503. doi: 10.1007/s10620-012-2351-9 CrossRefPubMedGoogle Scholar
  20. 20.
    Gillespie CJ, Sutherland AD, Mossop PJ, Woods RJ, Keck JO, Heriot AG (2010) Mesenteric embolization for lower gastrointestinal bleeding. Dis Colon rectum 53(9):1258–1264. doi: 10.1007/DCR.0b013e3181e10e90
  21. 21.
    Chung MJ, Cheon JH, Kim SU, Park JJ, Kim TI, Kim NK, Kim WH (2010) Response rates to medical treatments and long-term clinical outcomes of nonsurgical patients with intestinal Behcet disease. J Clin Gastroenterol 44(6):e116–e122. doi: 10.1097/MCG.0b013e3181c8a50f PubMedGoogle Scholar
  22. 22.
    Kimura Y, Asako K, Kikuchi H, Kono H (2016) Characteristics of patients with intestinal Behcet’s disease requiring treatment with immunosuppressants or anti-TNFalpha antibody. Mod Rheumatol 26(1):132–137. doi: 10.3109/14397595.2015.1056956 CrossRefPubMedGoogle Scholar
  23. 23.
    Yim SM, Kim DH, Lee HJ, Jang HW, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH (2014) Mucosal healing predicts the long-term prognosis of intestinal Behcet’s disease. Dig Dis Sci 59(10):2529–2535. doi: 10.1007/s10620-014-3198-z CrossRefPubMedGoogle Scholar
  24. 24.
    Belaiche J, Louis E, D’Haens G, Cabooter M, Naegels S, De Vos M, Fontaine F, Schurmans P, Baert F, De Reuck M, Fiasse R, Holvoet J, Schmit A, Van Outryve M (1999) Acute lower gastrointestinal bleeding in Crohn’s disease: characteristics of a unique series of 34 patients. Belgian IBD Research Group. Am J Gastroenterol 94(8):2177–2181. doi: 10.1111/j.1572-0241.1999.01291.x CrossRefPubMedGoogle Scholar
  25. 25.
    Cirocco WC, Reilly JC, Rusin LC (1995) Life-threatening hemorrhage and exsanguination from Crohn’s disease. Report of four cases. Dis Colon Rectum 38(1):85–95CrossRefPubMedGoogle Scholar
  26. 26.
    Takada Y, Saigenji K (2003) Is intestinal Behcet’s disease in fact an enterocolitis or an ulcer disease, and is steroid treatment useful or harmful? J Gastroenterol 38(10):1015–1016. doi: 10.1007/s00535-003-1214-8 CrossRefPubMedGoogle Scholar
  27. 27.
    Bernstein CN (2015) Treatment of IBD: where we are and where we are going. Am J Gastroenterol 110(1):114–126. doi: 10.1038/ajg.2014.357 CrossRefPubMedGoogle Scholar
  28. 28.
    Sohn IW, Kim ST, Kim B, Lee HJ, Park SJ, Hong SP, Kim TI, Kim WH, Cheon JH (2016) Efficacy of adalimumab in Korean patients with Crohn’s disease. Gut Liver 10(2):255–261. doi: 10.5009/gnl15165 CrossRefPubMedGoogle Scholar
  29. 29.
    Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, Buning C, Cohain A, Cichon S, D’Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H, International IBDGC, Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491(7422):119–124. doi: 10.1038/nature11582 CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Shen L, Su L, Turner JR (2009) Mechanisms and functional implications of intestinal barrier defects. Dig Dis 27(4):443–449. doi: 10.1159/000233282 CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Bryant RV, Burger DC, Delo J, Walsh AJ, Thomas S, von Herbay A, Buchel OC, White L, Brain O, Keshav S, Warren BF, Travis SP (2016) Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-up. Gut 65(3):408–414. doi: 10.1136/gutjnl-2015-309598 CrossRefPubMedGoogle Scholar
  32. 32.
    Mao R, Hu PJ (2016) The future of IBD therapy: where are we and where should we go next? Dig Dis 34(1–2):175–179. doi: 10.1159/000443135 CrossRefPubMedGoogle Scholar
  33. 33.
    Lee JH, Cheon JH, Jeon SW, Ye BD, Yang SK, Kim YH, Lee KM, Im JP, Kim JS, Lee CK, Kim HJ, Kim EY, Kim KO, Jang BI, Kim WH (2013) Efficacy of infliximab in intestinal Behcet’s disease: a Korean multicenter retrospective study. Inflamm Bowel Dis 19(9):1833–1838. doi: 10.1097/MIB.0b013e31828f19c9 PubMedGoogle Scholar
  34. 34.
    Kimura M, Tsuji Y, Iwai M, Inagaki M, Madian A, Yoshino T, Matsuura M, Nakase H (2015) Usefulness of adalimumab for treating a case of intestinal Behcet’s disease with trisomy 8 Myelodysplastic syndrome. Intest Res 13(2):166–169. doi: 10.5217/ir.2015.13.2.166 CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Pardi DS, Loftus EV Jr, Tremaine WJ, Sandborn WJ, Alexander GL, Balm RK, Gostout CJ (1999) Acute major gastrointestinal hemorrhage in inflammatory bowel disease. Gastrointest Endosc 49(2):153–157CrossRefPubMedGoogle Scholar
  36. 36.
    Barreiro de Acosta M, Seijo Rios S, Dominguez Munoz JE (2007) Life-threatening acute lower gastrointestinal bleeding in patients with Crohn’s disease. Rev Esp Enferm Dig 99(7):388–391CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2016

Authors and Affiliations

  • Jihye Park
    • 1
  • Jae Hee Cheon
    • 1
    • 2
    Email author
  • Yong Eun Park
    • 1
  • Yoon Jee Lee
    • 1
  • Hyun Jung Lee
    • 1
    • 2
  • Soo Jung Park
    • 1
    • 2
  • Sung Pil Hong
    • 1
    • 2
  • Tae Il Kim
    • 1
    • 2
  • Won Ho Kim
    • 1
    • 2
  1. 1.Department of Internal MedicineYonsei University College of MedicineSeoulRepublic of Korea
  2. 2.Institute of GastroenterologyYonsei University College of MedicineSeoulSouth Korea

Personalised recommendations